Sign in

    Brad Mas

    Research Analyst at Needham and Company

    Brad Mas is a Research Analyst at Needham and Company, specializing in equity research with a focus on growth-oriented sectors such as technology and healthcare. He is known for covering companies involved in acquisition activities and product development, having engaged directly with management teams about integration and performance of recent acquisitions. Although specific performance metrics and success rates are not published publicly, his role encompasses deep-dive analysis into cancelled programs and acquisition strategies, supporting investment decisions at the firm. Mas's career and credentials, including securities licenses and professional registrations, are not widely disclosed, and his LinkedIn profile does not publicly detail previous experience or notable awards.

    Brad Mas's questions to NEW PACIFIC METALS (NEWP) leadership

    Brad Mas's questions to NEW PACIFIC METALS (NEWP) leadership • Q1 2015

    Question

    Brad Mas of Needham and Company inquired about the cancelled development program, the integration and performance of recent acquisitions, and the outlook for operating margin expansion.

    Answer

    President and CEO Bob Phillippy clarified that the development program was cancelled due to the customer's time constraints and need for a lower-risk solution, not a failure by Newport. He also confirmed that revenue expectations for the V-Gen and FEMTOLASERS acquisitions remain on track. CFO Chuck Cargile added that the company is committed to reaching a 15% non-GAAP operating margin, driven by leverage in both the Optics and Lasers segments.

    Ask Fintool Equity Research AI